Italia markets open in 4 hours 6 minutes

JNJ Mar 2025 170.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,8000+1,1500 (+43,40%)
In data: 01:59PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,6500
Aperto3,8000
Denaro2,9900
Lettera4,3500
Prezzo d'esercizio170,00
Scadenza2025-03-21
Min-Max giorno3,8000 - 3,8000
Contratto - Min-MaxN/D
Volume2
Open Interest23
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA